Show Notes
In this episode of Building AI Boston, we’re honored to welcome Dr. Catherine Brownstein, a leading force in pediatric genomics and rare disease research at Boston Children’s Hospital. Dr. Brownstein shares how AI is revolutionizing how we diagnose and treat rare diseases, her collaboration with OpenAI, and why Boston is a global hub for medical innovation. With over 15 years of experience in bioinformatics, genomics, and computational biology, she walks us through groundbreaking AI projects that are changing lives—especially for children with conditions that once defied diagnosis.
Whether you're interested in healthcare innovation, artificial intelligence, or the future of personalized medicine, this is a must-watch conversation.
Guest: Dr. Catherine Brownstein Scientific Director of the Manton Center for Orphan Disease Research Boston Children’s Hospital / Assistant Professor at Harvard Medical School
Learn more about her work: https://www.childrenshospital.org/research/researchers/catherine-brownstein https://connects.catalyst.harvard.edu/Profiles/display/Person/47081
Watch more episodes: https://www.youtube.com/@BuildingAIBoston#AIinHealthcare #BostonChildrensHospital #RareDiseases #CatherineBrownstein #ArtificialIntelligence #OpenAI #Genomics #PrecisionMedicine #Pediatrics #BuildingAIBoston #HarvardMedicalSchool #MedicalInnovation #BostonAI #HealthcareTech Learn more about your ad choices. Visit megaphone.fm/adchoices
More from Building AI Boston
What happens when AI becomes more than a tool and starts becoming part of the creative process itself?
Boston has no shortage of people building ambitious AI products. The harder part is turning those ideas into companies and technologies that can actually work, scale, and succeed inside an enterprise.
What does it take to build an AI ecosystem that starts in one place but reaches far beyond it?
In this exciting episode of Building AI Boston, hosts Anna and Chris sit down with AI marketing strategist, speaker, and entrepreneur Molly Mahoney to explore how artificial intelligence is transforming the way businesses connect, communicate, and grow.
AI is really good at coming up with plans. It's not always great at executing them. David Wong thinks that gap is the whole story for legal AI right now, and it's why Thomson Reuters has been building the way they have.